SYNDAX PHARMACEUTICALS INC's ticker is SNDX and the CUSIP is 87164F105. A total of 66 filers reported holding SYNDAX PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $39,233,197 | -7.3% | 1,910,623 | +7.4% | 0.00% | -25.0% |
| Q1 2024 | $42,335,205 | +27.6% | 1,778,548 | +15.9% | 0.00% | +33.3% |
| Q4 2023 | $33,176,654 | +67.9% | 1,535,055 | +12.8% | 0.00% | +50.0% |
| Q3 2023 | $19,763,029 | -28.5% | 1,360,920 | +3.0% | 0.00% | -33.3% |
| Q2 2023 | $27,650,692 | +6.6% | 1,321,103 | +7.6% | 0.00% | 0.0% |
| Q1 2023 | $25,926,940 | +92426.8% | 1,227,601 | +11.5% | 0.00% | -25.0% |
| Q4 2022 | $28,021 | -99.9% | 1,101,029 | +13.7% | 0.00% | 0.0% |
| Q3 2022 | $23,264,000 | +33.2% | 968,129 | +6.6% | 0.00% | +33.3% |
| Q2 2022 | $17,467,000 | +17.5% | 907,856 | +6.1% | 0.00% | +50.0% |
| Q1 2022 | $14,867,000 | -11.2% | 855,415 | +11.9% | 0.00% | 0.0% |
| Q4 2021 | $16,737,000 | +19.5% | 764,627 | +4.3% | 0.00% | 0.0% |
| Q3 2021 | $14,011,000 | +15.4% | 733,220 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $12,138,000 | -4.2% | 706,942 | +24.7% | 0.00% | 0.0% |
| Q1 2021 | $12,676,000 | +23.1% | 566,923 | +22.4% | 0.00% | 0.0% |
| Q4 2020 | $10,301,000 | +69.4% | 463,176 | +12.4% | 0.00% | +100.0% |
| Q3 2020 | $6,081,000 | -1.0% | 412,013 | -0.6% | 0.00% | 0.0% |
| Q2 2020 | $6,145,000 | +68.1% | 414,690 | +24.4% | 0.00% | 0.0% |
| Q1 2020 | $3,655,000 | -30.6% | 333,258 | -44.5% | 0.00% | 0.0% |
| Q4 2019 | $5,270,000 | +146.5% | 600,402 | +109.8% | 0.00% | – |
| Q3 2019 | $2,138,000 | -14.5% | 286,238 | +6.6% | 0.00% | -100.0% |
| Q2 2019 | $2,500,000 | +141.1% | 268,557 | +35.9% | 0.00% | – |
| Q1 2019 | $1,037,000 | -35.3% | 197,606 | -45.2% | 0.00% | – |
| Q4 2018 | $1,602,000 | +14.3% | 360,398 | +107.8% | 0.00% | – |
| Q3 2018 | $1,401,000 | +18.5% | 173,431 | +3.0% | 0.00% | – |
| Q2 2018 | $1,182,000 | -46.2% | 168,391 | +9.0% | 0.00% | -100.0% |
| Q1 2018 | $2,199,000 | +63.6% | 154,556 | +0.7% | 0.00% | – |
| Q4 2017 | $1,344,000 | -12.0% | 153,483 | +17.4% | 0.00% | -100.0% |
| Q3 2017 | $1,528,000 | -13.2% | 130,680 | +3.7% | 0.00% | 0.0% |
| Q2 2017 | $1,760,000 | +29.7% | 125,999 | +27.3% | 0.00% | 0.0% |
| Q1 2017 | $1,357,000 | +111.4% | 98,962 | +10.5% | 0.00% | – |
| Q4 2016 | $642,000 | -51.3% | 89,552 | +2.9% | 0.00% | -100.0% |
| Q3 2016 | $1,319,000 | +347.1% | 87,035 | +190.3% | 0.00% | – |
| Q2 2016 | $295,000 | – | 29,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,025,000 | $19,588,000 | 3.91% |
| Ghost Tree Capital, LLC | 575,000 | $10,988,000 | 3.21% |
| Avidity Partners Management LP | 4,823,400 | $92,175,000 | 2.04% |
| BVF INC/IL | 2,486,429 | $47,516,000 | 1.85% |
| FRAZIER MANAGEMENT LLC | 1,188,135 | $22,705,000 | 1.82% |
| Nantahala Capital Management | 2,657,159 | $50,778,000 | 1.60% |
| Boxer Capital, LLC | 2,287,782 | $43,720,000 | 1.53% |
| ACUTA CAPITAL PARTNERS, LLC | 206,126 | $3,939,000 | 1.39% |
| SPHERA FUNDS MANAGEMENT LTD. | 750,603 | $14,344,000 | 1.20% |
| PFM Health Sciences, LP | 1,856,738 | $35,482,000 | 1.04% |